Literature DB >> 29256922

Sleep disturbance in mild cognitive impairment: a systematic review of recent findings.

Sharon L Naismith1,2,3, Loren Mowszowski1,2,3.   

Abstract

PURPOSE OF REVIEW: Research interest in sleep as a risk factor for dementia has grown, warranting an update in advances over the last 18 months, particularly in the mild cognitive impairment (MCI) stage in which interventions may be best targeted. RECENT
FINDINGS: The current systematic review includes empiric research articles published since 2016 that have investigated sleep (excluding obstructive sleep apnea) in MCI. Published articles include case-control studies, those examining clinical correlates of sleep problems, sleep microarchitecture, neuroimaging studies and novel cerebrospinal and blood-based markers.
SUMMARY: Evidence accumulated since 2016 continues to demonstrate that people with MCI manifest sleep disturbance on self-report measures. Neurophysiologically, sleep disturbance in MCI appears to be associated with diminished sleep spindles, key processes involved in overnight memory consolidation. Those with both MCI and sleep disturbance appear to have more pronounced functional connectivity alterations in temporoparietal brain regions and higher levels of the wake-promoting neurotransmitter orexin in cerebrospinal fluid than those with MCI alone. Novel findings also suggest that sleep may mediate homocysteine and oxidative stress mechanisms, warranting further exploration. Further studies focusing on novel interventions for sleep and circadian disturbance in MCI are warranted, particularly those targeting sleep spindles, orexin/hypocretin and the oxidative stress system.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29256922     DOI: 10.1097/YCO.0000000000000397

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  10 in total

1.  Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications.

Authors:  Shanna L Burke; Tianyan Hu; Christine E Spadola; Tan Li; Mitra Naseh; Aaron Burgess; Tamara Cadet
Journal:  Sleep Med       Date:  2018-09-20       Impact factor: 3.492

2.  Sleep, Mild Cognitive Impairment, and Interventions for Sleep Improvement: An Integrative Review.

Authors:  Maral Torossian; Sarah Marie Fiske; Cynthia S Jacelon
Journal:  West J Nurs Res       Date:  2021-01-16       Impact factor: 1.774

3.  Decision Tree for Early Detection of Cognitive Impairment by Community Pharmacists.

Authors:  Maria Teresa Climent; Juan Pardo; Francisco Javier Muñoz-Almaraz; Maria Dolores Guerrero; Lucrecia Moreno
Journal:  Front Pharmacol       Date:  2018-10-29       Impact factor: 5.810

4.  Acoustic enhancement of sleep slow oscillations in mild cognitive impairment.

Authors:  Nelly A Papalambros; Sandra Weintraub; Tammy Chen; Daniela Grimaldi; Giovanni Santostasi; Ken A Paller; Phyllis C Zee; Roneil G Malkani
Journal:  Ann Clin Transl Neurol       Date:  2019-07-01       Impact factor: 4.511

5.  Characteristics of Sleep Structure Assessed by Objective Measurements in Patients With Amnestic Mild Cognitive Impairment: A Meta-Analysis.

Authors:  Sijie Cai; Tingting Li; Li Zhang; Longhua Shi; Jingling Liao; Wenfang Li; Guangwen Cheng; Wei Tan; Shuang Rong
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

6.  Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled study.

Authors:  Zoe Menczel Schrire; Craig L Phillips; Shantel L Duffy; Nathaniel S Marshall; Loren Mowszowski; Haley M La Monica; Christopher J Gordon; Julia L Chapman; Bandana Saini; Simon J G Lewis; Sharon L Naismith; Ronald R Grunstein; Camilla M Hoyos
Journal:  BMJ Open       Date:  2021-02-10       Impact factor: 2.692

Review 7.  A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment.

Authors:  Meghan K Mattos; Angela Chang; Katherine Pitcher; Carley Whitt; Lee M Ritterband; Mark S Quigg
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

8.  Efficacy and safety of Hominis placenta pharmacopuncture on mild cognitive impairment: Randomized, double blind, placebo-controlled, multi-center trial.

Authors:  Yunna Kim; Jae Hyok Lee; In Chul Jung; Yoon Ji Eom; Seung-Hun Cho
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

9.  Toward a theory-based specification of non-pharmacological treatments in aging and dementia: Focused reviews and methodological recommendations.

Authors:  Sietske A M Sikkes; Yi Tang; Roos J Jutten; Linda M P Wesselman; Lyn S Turkstra; Henry Brodaty; Linda Clare; Erin Cassidy-Eagle; Kay L Cox; Gaël Chételat; Sophie Dautricourt; Klodian Dhana; Hiroko Dodge; Rose-Marie Dröes; Benjamin M Hampstead; Thomas Holland; Amit Lampit; Kate Laver; Antoine Lutz; Nicola T Lautenschlager; Susan M McCurry; Franka J M Meiland; Martha Clare Morris; Kimberly D Mueller; Ruth Peters; Gemma Ridel; Aimee Spector; Jenny T van der Steen; Jeanette Tamplin; Zara Thompson; Alex Bahar-Fuchs
Journal:  Alzheimers Dement       Date:  2020-11-20       Impact factor: 21.566

10.  Physical Activity and Inhibitory Control: The Mediating Role of Sleep Quality and Sleep Efficiency.

Authors:  Lin Li; Qian Yu; Wenrui Zhao; Fabian Herold; Boris Cheval; Zhaowei Kong; Jinming Li; Notger Mueller; Arthur F Kramer; Jie Cui; Huawei Pan; Zhuxuan Zhan; Minqiang Hui; Liye Zou
Journal:  Brain Sci       Date:  2021-05-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.